Cargando…
A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin disease with pruritus, characterized by recurrent eczema with exacerbations and remissions. AD impairs patients’ QOL and places a heavy burden on patients. Recently, dupilumab, an anti–IL-4Rα antibody, was approved for the treatment of patients w...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659403/ https://www.ncbi.nlm.nih.gov/pubmed/34909737 http://dx.doi.org/10.1016/j.xjidi.2021.100042 |